Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions
(marketscreener.com) TORONTO, Oct. 12, 2023 — Optimind Pharma Corp. is pleased to announce that it has entered into an acquisition agreement dated October 12, 2023 with Wolf Acquisitions 1.0 Corp. , an arm’s length private British Columbia corporation, and 1…
TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) — Optimind Pharma Corp. (CSE: OMND) (the “Optimind” or the “Company”) is pleased to announce that it has entered into an acquisition agreement dated October 1…